Vishva Dixit

Vishva Mitra Dixit (born ) is a Kenyan-born American physician, biomedical researcher, and biotechnology executive whose discoveries transformed the modern understanding of programmed cell death, innate immunity, and inflammatory signaling.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Vishva Mitra Dixit (born ) is a Kenyan-born American physician, biomedical researcher, and biotechnology executive whose discoveries transformed the modern understanding of programmed cell death, innate immunity, and inflammatory signaling. He is Vice President of Early Discovery Research at Genentech and is internationally recognized for elucidating the molecular mechanisms of apoptosis, identifying the signaling pathways of death receptors, discovering critical components of the caspase cascade, and pioneering research on inflammasomes, pyroptosis, necroptosis, and inflammatory cell death.

His work has reshaped molecular and cellular biology and has had far-reaching implications for cancer biology, immunology, infectious diseases, neurodegeneration, and drug discovery. Dixit has authored more than 300 scientific publications, many of which focuses on molecular biology and immunology.

Death and legacy

His discoveries established entirely new paradigms for understanding how cells undergo programmed death and how the innate immune system detects pathogens and tissue injury.…

Early life

Vishva Mitra Dixit (born ) is a Kenyan-born American physician, biomedical researcher, and biotechnology executive whose discoveries transformed the modern understanding of programmed cell death, innate immunity, and inflammatory signaling. He is Vice President of Early Discovery Research at Genentech and is internationally recognized for elucidating the molecular mechanisms of apoptosis, identifying the signaling pathways of death receptors, discovering critical components of the caspase cascade, and pioneering research on inflammasomes, pyroptosis, necroptosis, and inflammatory cell death.

His work has reshaped molecular and cellular biology and has had far-reaching implications for cancer biology, immunology, infectious diseases, neurodegeneration, and drug discovery. Dixit has authored more than 300 scientific publications, many of which focuses on molecular biology and immunology.

His discoveries established entirely new paradigms for understanding how cells undergo programmed death and how the innate immune system detects pathogens and tissue injury. Among his contributions are the identification of caspase-3 and caspase-8 as central regulators of apoptosis, elucidation of death receptor signaling through adaptor proteins and protease cascades, discovery of the noncanonical inflammasome pathway mediated by caspase-11, identification of Gasdermin D as the molecular executor of pyroptosis, characterization of RHIM-mediated signaling in necroptosis, and the demonstration that NINJ1 controls plasma membrane rupture during inflammatory cell death.

Career

He has received awards including the Vilcek Prize in Biomedical Science , the William B. Coley Award for Distinguished Research in Basic and Tumor Immunology, the Dr. A.H. Heineken Prize for Medicine, the Dawson Prize in Genetics , the Clowes Award of the American Association for Cancer Research, and the Gutenberg Prize. He is an elected member of the National Academy of Sciences, the National Academy of Medicine, the American Academy of Arts and Sciences and a foreign member of The Royal Society.

His honours include the Dr. A.H. Heineken Prize for Medicine, the Vilcek Prize, the William B. Coley Award, and the Gutenberg Research Award. In 2026, he was elected to the American Philosophical Society.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1377760404 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

33 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.